Risk of ipsilateral and contralateral cancer in BRCA mutation carriers with breast cancer

被引：3
|
作者：
Green L. [1 ]
Meric-Bernstam F. [1 ]
机构：
[1] Department of Surgical Oncology, University of Texas, M. D. Anderson Cancer Center, Houston, TX 77030
来源：
Current Breast Cancer Reports | 2011年 / 3卷 / 3期
关键词：
BRCA1; BRCA2; Contralateral breast cancer; Prophylactic mastectomy;
D O I：
10.1007/s12609-011-0047-3
中图分类号：
学科分类号：
摘要：
BRCA1 and BRCA2 mutation carriers with breast cancer have a high risk of ipsilateral breast cancer tumor recurrence (IBTR) and a high lifetime risk of contralateral breast cancer (CBC). The IBTR risk is significantly higher in women who elect breast conservation. Oophorectomy has a protective effect for both ipsilateral breast tumor recurrence and CBC. Patients with younger age of breast cancer onset have a significantly greater risk of CBC. Given the higher risk of IBTR and CBC, when indicated, patients with breast cancer should undergo genetic counseling early in their treatment course to assist them in their surgical decision-making. Knowledge of expected outcomes for BRCA1/2 mutation carriers following breast cancer treatment can help in appropriately counseling patients and personalizing cancer therapy. © 2011 Springer Science+Business Media, LLC.
引用
收藏
页码：151 / 155
页数：4
相关论文
共 50 条
  • [31] Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers
    T C van Sprundel
    M K Schmidt
    M A Rookus
    R Brohet
    C J van Asperen
    E J Th Rutgers
    L J van‘t Veer
    R A E M Tollenaar
    British Journal of Cancer, 2005, 93 : 287 - 292
  • [32] Impact of BRCA mutation on the survival and risk of contralateral breast cancer in Asian breast cancer patients
    Lin, Po-Han
    Chen, Shin-Cheh
    Tseng, Ling-Ming
    Chang, King-Jen
    Huang, Ai-Chu
    Cheng, Kuo-Chih
    Yang, Karen
    Wu, Hui-Chen
    Chao, Tsu-Yi
    Chang, Yuan-Ching
    Lin, Peng-Chan
    Kuo, Wen-Hung
    Kuo, Wen-Lin
    Lin, Ching-Hung
    Chen, Huo-Mu
    Yeh, Dah-Cherng
    Liu, Liang-Chih
    Liu, Chun-Yu
    Wang, Ming-Yang
    Lo, Chiao
    Lu, Yen-Shen
    Huang, Chiun-Sheng
    BREAST CANCER RESEARCH AND TREATMENT, 2022, 192 (03) : 629 - 637
  • [33] Contralateral Breast Cancer in BRCA1/2 Mutation Carriers: Risk Assessment by Age at Diagnosis of the First Primary Breast Cancer
    Hooning, M. J.
    Heemskerk-Gerritsen, B. A. M.
    Jager, A.
    Collee, M.
    van den Ouweland, A.
    Menke-Pluymers, M. B. E.
    van Geel, B.
    van Doorn, L.
    Tilanus-Linthorst, M. M. A.
    Bartels, C. C. M.
    Seynaeve, C.
    CANCER RESEARCH, 2009, 69 (24) : 531S - 532S
  • [34] Impact of BRCA mutation on the survival and risk of contralateral breast cancer in Asian breast cancer patients
    Po-Han Lin
    Shin-Cheh Chen
    Ling-Ming Tseng
    King-Jen Chang
    Ai-Chu Huang
    Kuo-Chih Cheng
    Karen Yang
    Hui-Chen Wu
    Tsu-Yi Chao
    Yuan-Ching Chang
    Peng-Chan Lin
    Wen-Hung Kuo
    Wen-Lin Kuo
    Ching-Hung Lin
    Huo-Mu Chen
    Dah-Cherng Yeh
    Liang-Chih Liu
    Chun-Yu Liu
    Ming-Yang Wang
    Chiao Lo
    Yen-Shen Lu
    Chiun-Sheng Huang
    Breast Cancer Research and Treatment, 2022, 192 : 629 - 637
  • [35] The risk of primary and contralateral breast cancer after ovarian cancer in BRCA1/BRCA2 mutation carriers Implications for Counseling
    Vencken, Peggy M. L. H.
    Kriege, Mieke
    Hooning, Maartje
    Menke-Pluymers, Marian B.
    Heemskerk-Gerritsen, Bernadette A. M.
    van Doorn, Lena C.
    Collee, Margriet M.
    Jager, Agnes
    van Montfort, Cees
    Burger, Curt W.
    Seynaeve, Caroline
    CANCER, 2013, 119 (05) : 955 - 962
  • [36] Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
    Kuchenbaecker, Karoline B.
    Hopper, John L.
    Barnes, Daniel R.
    Phillips, Kelly-Anne
    Mooij, Thea M.
    Roos-Blom, Marie-Jose
    Jervis, Sarah
    van Leeuwen, Flora E.
    Milne, Roger L.
    Andrieu, Nadine
    Goldgar, David E.
    Terry, Mary Beth
    Rookus, Matti A.
    Easton, Douglas F.
    Antoniou, Antonis C.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 317 (23): : 2402 - 2416
  • [37] Prophylactic irradiation to the contralateral breast for BRCA mutation carriers with early-stage breast cancer
    Evron, E.
    Ben-David, A. M.
    Goldberg, H.
    Fried, G.
    Kaufman, B.
    Catane, R.
    Pfeffer, M. R.
    Geffen, D. B.
    Chernobelsky, P.
    Karni, T.
    Abdah-Bortnyak, R.
    Rosengarten, O.
    Matceyevsky, D.
    Inbar, M.
    Kuten, A.
    Corn, B. W.
    ANNALS OF ONCOLOGY, 2019, 30 (03) : 412 - 417
  • [38] Risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: impact of adjuvant systemic treatment
    Hooning, M.
    Jager, A.
    Koppert, L.
    Van Deurzen, C.
    Collee, M.
    Hollestelle, A.
    Seynaeve, C.
    EUROPEAN JOURNAL OF CANCER, 2016, 57 : S140 - S140
  • [39] Association of tamoxifen use and reduced risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers
    KA Phillips
    RL Milne
    MA Rookus
    D Goldgar
    M Friedlander
    SA McLachlan
    S Buys
    AC Antoniou
    K Birch
    MB Terry
    DF Easton
    P Weideman
    M Daly
    N Andrieu
    EM John
    MJ Hooning
    IL Andrulis
    T Caldes
    H Olsson
    JL Hopper
    Hereditary Cancer in Clinical Practice, 10 (Suppl 2)
  • [40] Contralateral breast cancer risk with radiation therapy in BRCA mutation carriers: what do we tell patients?
    Lee, Minna K.
    Robson, Mark E.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2023, 115 (11): : 1243 - 1245
12345